1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Human Microbiome Market, by Disease
6.1. Introduction
6.2. Acute Diarrhea
6.3. Autoimmune Disorders
6.4. Cancer
6.5. Diabetes
6.6. Mental Disorders
6.7. Obesity

7. Human Microbiome Market, by Technology
7.1. Introduction
7.2. 16s rRNA Sequencing
7.3. Cell Culture Technology
7.4. Computational Tools
7.5. High-Throughput Technology
7.6. Metagenomic Sequencing
7.7. Omics Technology

8. Human Microbiome Market, by Product
8.1. Introduction
8.2. Diagnostic Devices
8.3. Drugs
8.4. Foods
8.5. Prebiotic & Probiotics

9. Human Microbiome Market, by Therapeutic Area
9.1. Introduction
9.2. Gastrointestinal Disorders
9.3. Metabolic Disorders
9.4. Skin Disorders
9.5. Women's Health

10. Human Microbiome Market, by Application
10.1. Introduction
10.2. Diagnostics
10.3. Therapeutics

11. California Human Microbiome Market

12. Florida Human Microbiome Market

13. Illinois Human Microbiome Market

14. New York Human Microbiome Market

15. Ohio Human Microbiome Market

16. Pennsylvania Human Microbiome Market

17. Texas Human Microbiome Market

18. Competitive Landscape
18.1. FPNV Positioning Matrix
18.1.1. Quadrants
18.1.2. Business Strategy
18.1.3. Product Satisfaction
18.2. Market Ranking Analysis
18.3. Market Share Analysis, By Key Player
18.4. Competitive Scenario
18.4.1. Merger & Acquisition
18.4.2. Agreement, Collaboration, & Partnership
18.4.3. New Product Launch & Enhancement
18.4.4. Investment & Funding
18.4.5. Award, Recognition, & Expansion

19. Company Usability Profiles
19.1. DuPont de Nemours, Inc.
19.2. Enterome Bioscience
19.3. Evelo Biosciences, Inc.
19.4. Ferring Holding SA
19.5. Merck Sharp & Dohme Corp.
19.6. Metabiomics Corporation
19.7. Osel, Inc.
19.8. Second Genome, Inc.
19.9. Seres Therapeutics, Inc.
19.10. Synlogic Inc.
19.11. Synthetic Biologics Inc.
19.12. Vedanta Biosciences, Inc.
19.13. Yakult Honsha Co., Ltd.

20. Appendix
20.1. Discussion Guide
20.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES HUMAN MICROBIOME MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES HUMAN MICROBIOME MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES HUMAN MICROBIOME MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2026
FIGURE 7. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY CANCER, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIABETES, 2018-2026 (USD MILLION)
FIGURE 14. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 15. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, 2018-2026 (USD MILLION)
FIGURE 16. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 17. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY OBESITY, 2018-2026 (USD MILLION)
FIGURE 18. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 19. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
FIGURE 20. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2026
FIGURE 22. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2026 (USD MILLION)
FIGURE 23. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 24. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, 2018-2026 (USD MILLION)
FIGURE 25. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 26. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, 2018-2026 (USD MILLION)
FIGURE 27. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 28. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, 2018-2026 (USD MILLION)
FIGURE 29. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 30. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, 2018-2026 (USD MILLION)
FIGURE 31. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 32. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, 2018-2026 (USD MILLION)
FIGURE 33. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 34. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 35. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2026
FIGURE 37. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2026 (USD MILLION)
FIGURE 38. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 39. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DRUGS, 2018-2026 (USD MILLION)
FIGURE 40. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 41. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY FOODS, 2018-2026 (USD MILLION)
FIGURE 42. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 43. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, 2018-2026 (USD MILLION)
FIGURE 44. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 45. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2020 VS 2026 (%)
FIGURE 46. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2020 VS 2026 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2026
FIGURE 48. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2026 (USD MILLION)
FIGURE 49. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 50. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, 2018-2026 (USD MILLION)
FIGURE 51. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 52. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, 2018-2026 (USD MILLION)
FIGURE 53. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 54. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY WOMEN'S HEALTH, 2018-2026 (USD MILLION)
FIGURE 55. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY WOMEN'S HEALTH, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 56. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 57. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 58. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2026
FIGURE 59. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2026 (USD MILLION)
FIGURE 60. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 61. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2026 (USD MILLION)
FIGURE 62. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 63. UNITED STATES HUMAN MICROBIOME MARKET: FPNV POSITIONING MATRIX
FIGURE 64. UNITED STATES HUMAN MICROBIOME MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 65. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES HUMAN MICROBIOME MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES HUMAN MICROBIOME MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES HUMAN MICROBIOME MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY STATE, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY STATE, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 23. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2026 (USD MILLION)
TABLE 24. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 25. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 27. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY WOMEN'S HEALTH, BY STATE, 2018-2026 (USD MILLION)
TABLE 28. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 29. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 30. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 31. UNITED STATES HUMAN MICROBIOME MARKET: SCORES
TABLE 32. UNITED STATES HUMAN MICROBIOME MARKET: BUSINESS STRATEGY
TABLE 33. UNITED STATES HUMAN MICROBIOME MARKET: PRODUCT SATISFACTION
TABLE 34. UNITED STATES HUMAN MICROBIOME MARKET: RANKING
TABLE 35. UNITED STATES HUMAN MICROBIOME MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 36. UNITED STATES HUMAN MICROBIOME MARKET: MERGER & ACQUISITION
TABLE 37. UNITED STATES HUMAN MICROBIOME MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 38. UNITED STATES HUMAN MICROBIOME MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 39. UNITED STATES HUMAN MICROBIOME MARKET: INVESTMENT & FUNDING
TABLE 40. UNITED STATES HUMAN MICROBIOME MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 41. UNITED STATES HUMAN MICROBIOME MARKET: LICENSE & PRICING

Companies Mentioned

DuPont de Nemours, Inc.
Enterome Bioscience
Evelo Biosciences, Inc.
Ferring Holding SA
Merck Sharp & Dohme Corp.
Metabiomics Corporation
Osel, Inc.
Second Genome, Inc.
Seres Therapeutics, Inc.
Synlogic Inc.
Synthetic Biologics Inc.
Vedanta Biosciences, Inc.
Yakult Honsha Co., Ltd.